{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:16:41Z","timestamp":1792106201150,"version":"4.4.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Genetics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.tig.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T08:17:04Z","timestamp":1668241024000},"page":"74-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Genetic and epigenetic defects of the RNA modification machinery in cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Ines","family":"Orsolic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-6093","authenticated-orcid":false,"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tig.2022.10.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tig.2022.10.004_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.01.021","article-title":"Writers, readers and erasers of RNA modifications in cancer","volume":"474","author":"Esteve-Puig","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tig.2022.10.004_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tig.2022.10.004_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13059-020-02009-z","article-title":"Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures","volume":"21","author":"Begik","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of m6A, m5C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities","volume":"20","author":"Nombela","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tig.2022.10.004_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trecan.2018.01.006","article-title":"Deciphering the epitranscriptome in cancer","volume":"4","author":"Lian","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tig.2022.10.004_bb0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","article-title":"The U6 snRNA m6A methyltransferase METTL16 regulates SAM synthetase intron retention","volume":"169","author":"Pendleton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.10.004_bb0045","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1093\/nar\/gkz619","article-title":"The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112","volume":"47","author":"van Tran","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.10.004_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","article-title":"N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation","volume":"15","author":"Ma","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-022-01003-0","article-title":"Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine","volume":"7","author":"Xue","year":"2022","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.tig.2022.10.004_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tig.2022.10.004_bb0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s41588-022-01173-1","article-title":"RNA m6A regulates transcription via DNA demethylation and chromatin accessibility","volume":"54","author":"Deng","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.10.004_bb0075","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1111\/jcmm.16664","article-title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tig.2022.10.004_bb0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.omtn.2021.12.024","article-title":"METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination","volume":"27","author":"Shen","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tig.2022.10.004_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41392-022-01033-8","article-title":"RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis","volume":"7","author":"Zhu","year":"2022","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.tig.2022.10.004_bb0090","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","article-title":"The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.10.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg7073","article-title":"Regulation of telomere homeostasis and genomic stability in cancer by N6-adenosine methylation (m6A)","volume":"7","author":"Lee","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tig.2022.10.004_bb0100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10565-021-09627-8","article-title":"RNA methylation in mammalian development and cancer","volume":"37","author":"Song","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tig.2022.10.004_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gpb.2018.03.003","article-title":"Reversible RNA modification N1-methyladenosine (m1A) in mRNA and tRNA","volume":"16","author":"Zhang","year":"2018","journal-title":"Genomics Proteomics Bioinforma."},{"key":"10.1016\/j.tig.2022.10.004_bb0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.2040","article-title":"Transcriptome-wide mapping reveals reversible and dynamic N1-methyladenosine methylome","volume":"12","author":"Li","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","article-title":"Differential m6A, m6Am, and m1A demethylation mediated by FTO in the cell nucleus and cytoplasm","volume":"71","author":"Wei","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.10.004_bb0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41556-021-00709-7","article-title":"ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing","volume":"23","author":"Zhang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature24456","article-title":"The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution","volume":"551","author":"Safra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41592-019-0550-4","article-title":"Evolution of a reverse transcriptase to map N1-methyladenosine in human messenger RNA","volume":"16","author":"Zhou","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tig.2022.10.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119038119","article-title":"RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D","volume":"119","author":"Wu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.10.004_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-022-00385-3","article-title":"ALKBH3-dependent m1A demethylation of Aurora A mRNA inhibits ciliogenesis","volume":"8","author":"Kuang","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.tig.2022.10.004_bb0145","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/genes13050910","article-title":"m1A RNA modification in gene expression regulation","volume":"13","author":"Jin","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.tig.2022.10.004_bb0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/dna.2020.6214","article-title":"Molecular characteristics of N1-methyladenosine regulators and their correlation with overall cancer survival","volume":"40","author":"Li","year":"2021","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0155","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.tranon.2019.06.007","article-title":"m1A Regulated genes modulate PI3K\/AKT\/mTOR and ErbB pathways in gastrointestinal cancer","volume":"12","author":"Zhao","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tig.2022.10.004_bb0160","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.2020005823","article-title":"Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome","volume":"137","author":"Esteve-Puig","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tig.2022.10.004_bb0165","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210337","article-title":"Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer","volume":"41","author":"Zheng","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.tig.2022.10.004_bb0170","doi-asserted-by":"crossref","first-page":"15083","DOI":"10.1038\/s41598-020-72178-1","article-title":"Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma","volume":"10","author":"Shi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tig.2022.10.004_bb0175","article-title":"Comprehensive of N1-methyladenosine modifications patterns and immunological characteristics in ovarian cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tig.2022.10.004_bb0180","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.3390\/ijms221910302","article-title":"The impact of m1A methylation modification patterns on tumor immune microenvironment and prognosis in oral squamous cell carcinoma","volume":"22","author":"Gao","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.tig.2022.10.004_bb0185","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/iub.2534","article-title":"N1-methyladenosine profiling of long non-coding RNA in colorectal cancer","volume":"73","author":"Shi","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.tig.2022.10.004_bb0190","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1038\/s41467-020-17007-9","article-title":"The lncRNA lincNMR regulates nucleotide metabolism via a YBX1-RRM2 axis in cancer","volume":"11","author":"Gandhi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.10.004_bb0195","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1261\/rna.072124.119","article-title":"Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA","volume":"25","author":"Zhang","year":"2019","journal-title":"RNA"},{"key":"10.1016\/j.tig.2022.10.004_bb0200","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","article-title":"5-Methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs","volume":"21","author":"Chen","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.599340","article-title":"m5C RNA methylation primarily affects the ErbB and PI3K\u2013Akt signaling pathways in gastrointestinal cancer","volume":"7","author":"Xiang","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tig.2022.10.004_bb0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12967-020-02417-6","article-title":"Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tig.2022.10.004_bb0215","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cells9081758","article-title":"The RNA methyltransferase NSUN2 and its potential roles in cancer","volume":"9","author":"Chellamuthu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tig.2022.10.004_bb0220","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","article-title":"Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma","volume":"39","author":"Sun","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.tig.2022.10.004_bb0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04898-5","article-title":"Mitochondrial RNA modifications shape metabolic plasticity in metastasis","volume":"607","author":"Delaunay","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0230","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00401-019-02062-4","article-title":"Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program","volume":"138","author":"Janin","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tig.2022.10.004_bb0235","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/15384047.2021.1990631","article-title":"NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction","volume":"22","author":"Awah","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tig.2022.10.004_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103195","article-title":"The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation","volume":"63","author":"Yang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tig.2022.10.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24303","article-title":"Role of m5C RNA methylation regulators in colorectal cancer prognosis and immune microenvironment","volume":"36","author":"Fang","year":"2022","journal-title":"Clin. Lab. Anal."},{"key":"10.1016\/j.tig.2022.10.004_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.671821","article-title":"m5C-Related lncRNAs predict overall survival of patients and regulate the tumor immune microenvironment in lung adenocarcinoma","volume":"9","author":"Pan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0255","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tips.2022.03.008","article-title":"Decoding pseudouridine: an emerging target for therapeutic development","volume":"43","author":"Cerneckis","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tig.2022.10.004_bb0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/genes8110301","article-title":"RNA Pseudouridylation in physiology and medicine: for better and for worse","volume":"8","author":"Penzo","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.tig.2022.10.004_bb0265","series-title":"The Enzymes","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.enz.2017.02.001","article-title":"Posttranscriptional RNA pseudouridylation","volume":"41","author":"De Zoysa","year":"2017"},{"key":"10.1016\/j.tig.2022.10.004_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/biom8020038","article-title":"Turning uridines around: role of rRNA pseudouridylation in ribosome biogenesis and ribosomal function","volume":"8","author":"Penzo","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.tig.2022.10.004_bb0275","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molcel.2021.12.023","article-title":"Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing","volume":"82","author":"Martinez","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.10.004_bb0280","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1093\/nar\/gky811","article-title":"Landscape of the complete RNA chemical modifications in the human 80S ribosome","volume":"46","author":"Taoka","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.10.004_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004344","article-title":"Dual inhibition of DKC1 and MEK1\/2 synergistically restrains the growth of colorectal cancer cells","volume":"8","author":"Kan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tig.2022.10.004_bb0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/wrna.1266","article-title":"Small RNAs with big implications: new insights into H\/ACA snoRNA function and their role in human disease","volume":"6","author":"McMahon","year":"2015","journal-title":"WIREs RNA"},{"key":"10.1016\/j.tig.2022.10.004_bb0295","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41388-020-01570-y","article-title":"NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration","volume":"40","author":"Cui","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.tig.2022.10.004_bb0300","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10549-020-05999-3","article-title":"Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer","volume":"185","author":"Elsharawy","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tig.2022.10.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100115","article-title":"Age-associated proteomic signatures and potential clinically actionable targets of colorectal cancer","volume":"20","author":"Gong","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.tig.2022.10.004_bb0310","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s43018-021-00238-0","article-title":"Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis","volume":"2","author":"Cui","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tig.2022.10.004_bb0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/genes10020117","article-title":"RNA 2\u2032-O-methylation (Nm) modification in human diseases","volume":"10","author":"Dimitrova","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.tig.2022.10.004_bb0320","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41588-019-0502-z","article-title":"Germline NPM1 mutations lead to altered rRNA 2\u2032-O-methylation and cause dyskeratosis congenita","volume":"51","author":"Nachmani","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.10.004_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/biom8040106","article-title":"2\u2032-O-Methylation of ribosomal RNA: towards an epitranscriptomic control of translation?","volume":"8","author":"Monaco","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.tig.2022.10.004_bb0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15476286.2021.1991167","article-title":"The role of OncoSnoRNAs and ribosomal RNA 2\u2032-O-methylation in cancer","volume":"18","author":"Barros-Silva","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0335","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jmcb\/mjy072","article-title":"Mutant p53 in cancer therapy \u2013 the barrier or the path","volume":"11","author":"Zhou","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0340","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/boc.201400077","article-title":"Fibrillarin from Archaea to human","volume":"107","author":"Rodriguez-Corona","year":"2015","journal-title":"Biol. Cell."},{"key":"10.1016\/j.tig.2022.10.004_bb0345","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ncb3563","article-title":"AML1-ETO requires enhanced C\/D box snoRNA\/RNP formation to induce self-renewal and leukaemia","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0350","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.2019004121","article-title":"Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation","volume":"135","author":"Pauli","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tig.2022.10.004_bb0355","article-title":"Ribosomal RNA 2\u2032O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer. NAR","volume":"2","author":"Marcel","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.tig.2022.10.004_bb0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12943-020-01201-w","article-title":"Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2\u2032-O-methylation via NOP58 recruitment in colorectal cancer","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tig.2022.10.004_bb0365","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41556-021-00653-6","article-title":"A PRC2-independent function for EZH2 in regulating rRNA 2\u2032-O methylation and IRES-dependent translation","volume":"23","author":"Yi","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0370","article-title":"Hypoxia re-programs 2\u2032-O-Me modifications on ribosomal RNA","volume":"24","author":"Metge","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.tig.2022.10.004_bb0375","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10409238.2020.1856768","article-title":"To protect and modify double-stranded RNA \u2013 the critical roles of ADARs in development, immunity and oncogenesis","volume":"56","author":"Erdmann","year":"2021","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drup.2017.09.001","article-title":"In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic","volume":"32","author":"Ganem","year":"2017","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tig.2022.10.004_bb0385","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12935-018-0695-8","article-title":"ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R","volume":"18","author":"Zhang","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tig.2022.10.004_bb0390","first-page":"3369","article-title":"DNA editing in DNA\/RNA hybrids by adenosine deaminases that act on RNA","volume":"45","author":"Zheng","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.10.004_bb0395","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymeth.2018.11.016","article-title":"Current strategies for site-directed RNA editing using ADARs","volume":"156","author":"Montiel-Gonzalez","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.tig.2022.10.004_bb0400","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi\u2013Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tig.2022.10.004_bb0405","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-022-04878-9","article-title":"ADAR1 averts fatal type I interferon induction by ZBP1","volume":"607","author":"Jiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0410","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1038\/onc.2015.469","article-title":"Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis","volume":"35","author":"Anad\u00f3n","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.tig.2022.10.004_bb0415","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12876-020-01299-8","article-title":"ADAR expression and copy number variation in patients with advanced gastric cancer","volume":"20","author":"Behroozi","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.tig.2022.10.004_bb0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41388-020-01515-5","article-title":"Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer","volume":"40","author":"Kung","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.tig.2022.10.004_bb0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0430","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","article-title":"METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation","volume":"81","author":"Orellana","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.10.004_bb0435","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.ymthe.2021.08.005","article-title":"METTL1\/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression","volume":"29","author":"Ma","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tig.2022.10.004_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.675","article-title":"METTL1-m7G-EGFR\/EFEMP1 axis promotes the bladder cancer development","volume":"11","author":"Ying","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tig.2022.10.004_bb0445","doi-asserted-by":"crossref","first-page":"20785","DOI":"10.1073\/pnas.2003358117","article-title":"Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer","volume":"117","author":"Rossell\u00f3-Tortella","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.10.004_bb0450","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/leu.2017.99","article-title":"Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia","volume":"31","author":"Anad\u00f3n","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.tig.2022.10.004_bb0455","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3390\/cancers13081869","article-title":"Gene amplification-associated overexpression of the selenoprotein tRNA enzyme TRIT1 confers sensitivity to arsenic trioxide in small-cell lung cancer","volume":"13","author":"Coll-SanMartin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tig.2022.10.004_bb0460","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200662","article-title":"Loss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis","volume":"218","author":"Rosu","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tig.2022.10.004_bb0465","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41586-022-04677-2","article-title":"Reversible RNA phosphorylation stabilizes tRNA for cellular thermotolerance","volume":"605","author":"Ohira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.664872","article-title":"The emerging role of RNA modifications in DNA double-strand break repair","volume":"8","author":"Jimeno","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tig.2022.10.004_bb0475","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41588-019-0549-x","article-title":"N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells","volume":"52","author":"Abakir","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.10.004_bb0480","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2020.06.017","article-title":"METTL3 and N6-methyladenosine promote homologous recombination-mediated repair of DSBs by modulating DNA\u2013RNA hybrid accumulation","volume":"79","author":"Zhang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.10.004_bb0485","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41422-019-0235-7","article-title":"m6A promotes R-loop formation to facilitate transcription termination","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.tig.2022.10.004_bb0490","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-021-21921-x","article-title":"ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells","volume":"12","author":"Shiromoto","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.10.004_bb0495","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-021-25790-2","article-title":"ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair","volume":"12","author":"Jimeno","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.10.004_bb0500","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41586-022-04767-1","article-title":"Breakage of cytoplasmic chromosomes by pathological DNA base excision repair","volume":"606","author":"Tang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0505","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1039\/D1CB00075F","article-title":"Targeting the RNA demethylase FTO for cancer therapy","volume":"2","author":"Zhou","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0510","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11033-014-3817-y","article-title":"Single nucleotide polymorphisms of the FTO gene and cancer risk: an overview","volume":"42","author":"Hern\u00e1ndez-Caballero","year":"2015","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tig.2022.10.004_bb0515","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tig.2022.10.004_bb0520","doi-asserted-by":"crossref","first-page":"21441","DOI":"10.1073\/pnas.2000516117","article-title":"The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor","volume":"117","author":"Xiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.10.004_bb0525","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","article-title":"FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.tig.2022.10.004_bb0530","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1038\/s41388-021-01916-0","article-title":"FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis","volume":"40","author":"Ruan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.tig.2022.10.004_bb0535","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1021\/acsomega.1c01289","article-title":"Rational design of novel anticancer small-molecule RNA m6A demethylase ALKBH5 inhibitors","volume":"6","author":"Selberg","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.tig.2022.10.004_bb0540","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.10.004_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114446","article-title":"Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5","volume":"238","author":"Fang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tig.2022.10.004_bb0550","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.10.004_bb0555","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41375-022-01621-1","article-title":"Remodeling of the m6A RNA landscape in the conversion of acute lymphoblastic leukemia cells to macrophages","volume":"36","author":"Bueno-Costa","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.tig.2022.10.004_bb0560","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s42003-022-03420-x","article-title":"Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation","volume":"5","author":"Yang","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001292","article-title":"N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses","volume":"19","author":"Terajima","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0570","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","article-title":"ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism","volume":"22","author":"Tassinari","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.tig.2022.10.004_bb0575","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.ymthe.2022.03.003","article-title":"PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer","volume":"30","author":"Wu","year":"2022","journal-title":"Mol. Ther."}],"container-title":["Trends in Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952522002529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952522002529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:14:43Z","timestamp":1759191283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168952522002529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0168952522002529"],"URL":"https:\/\/doi.org\/10.1016\/j.tig.2022.10.004","relation":{},"ISSN":["0168-9525"],"issn-type":[{"value":"0168-9525","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and epigenetic defects of the RNA modification machinery in cancer","name":"articletitle","label":"Article Title"},{"value":"Trends in Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tig.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}